Literature DB >> 18208407

Human neutrophil alloantigens.

J Bux1.   

Abstract

OBJECTIVE: This review describes alloantigens currently listed in the human neutrophil alloantigen (HNA) system.
MATERIAL AND METHODS: Review of the literature.
RESULTS: Neutrophil antigens are implicated in a variety of clinical conditions including neonatal immune neutropenia, transfusion-related acute lung injury, refractoriness to granulocyte transfusions, febrile transfusion reactions, immune neutropenia after bone marrow transplantation, autoimmune neutropenia and drug-induced immune neutropenia. Seven antigens have been listed in the HNA system that are assigned to five antigen groups. Six antigens have been characterized biochemically and molecularly so that their primary structure is now known. As shown by regularly performed international granulocyte immunology workshops, a combination of granulocyte agglutination and immunofluorescence tests together with a panel of typed cells is currently the best means of detection.
CONCLUSIONS: Most of the HNA antigens have been well-characterized so that HNA typing as well as the detection of the corresponding antibodies are now reliably possible. This will improve diagnostics of neutrophil antibody-mediated clinical conditions as well as the prevention of transfusion-related acute lung injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18208407     DOI: 10.1111/j.1423-0410.2007.01031.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  31 in total

1.  Bad blood: a trigger for TRALI.

Authors:  Paul S Frenette; Narla Mohandas
Journal:  Nat Med       Date:  2010-04       Impact factor: 53.440

2.  Genotyping of human neutrophil antigens by polymerase chain reaction sequence-based typing.

Authors:  Junjun He; Wei Zhang; Wei Wang; Nanying Chen; Zhedong Han; Ji He; Faming Zhu; Hangjun Lv
Journal:  Blood Transfus       Date:  2013-06-19       Impact factor: 3.443

3.  HNA-1, -3, -4, and -5 genotyping using multiplex PCR among southern Thais: Developing continual HNA-1 null detection.

Authors:  Kamphon Intharanut; Wiradee Sasikarn; Supattra Mitundee; Oytip Nathalang
Journal:  J Clin Lab Anal       Date:  2018-08-13       Impact factor: 2.352

4.  External quality assessment in molecular immunohematology: the INSTAND proficiency test program.

Authors:  Willy A Flegel; Ion Chiosea; Ulrich J Sachs; Gregor Bein
Journal:  Transfusion       Date:  2013-09-20       Impact factor: 3.157

5.  Severe autoimmune neutropenia associated with acute autoimmune hepatitis.

Authors:  Ahmad M Wehbe; Birgir Johannsson; Thomas J Raife; Michelle Bleile; Adam Bell; Brian R Curtis; Thorvardur R Halfdanarson
Journal:  Int J Hematol       Date:  2010-04-02       Impact factor: 2.490

6.  Evolutionary history of copy-number-variable locus for the low-affinity Fcγ receptor: mutation rate, autoimmune disease, and the legacy of helminth infection.

Authors:  Lee R Machado; Robert J Hardwick; Jennifer Bowdrey; Helen Bogle; Timothy J Knowles; Manuela Sironi; Edward J Hollox
Journal:  Am J Hum Genet       Date:  2012-05-17       Impact factor: 11.025

Review 7.  Evaluation and management of patients with isolated neutropenia.

Authors:  Peter E Newburger; David C Dale
Journal:  Semin Hematol       Date:  2013-07       Impact factor: 3.851

8.  An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus.

Authors:  Edward J Hollox; Jan-Christoph Detering; Tushna Dehnugara
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

9.  Genotype frequency of human neutrophil antigen-3 polymorphisms in the Yi, Han, and Tibetan populations of China.

Authors:  Qing Chen; Kshitij Srivastava; Zhong Liu; Jianyu Xiao; Chengyin Huang; Jun Sun; Min Li; Willy Albert Flegel
Journal:  Transfusion       Date:  2015-11-23       Impact factor: 3.157

10.  A Case of Neonatal Neutropenia Due to Anti-Fc Gamma Receptor IIIb Isoantibodies Treated with Recombinant Human Granulocyte Colony Stimulating Factor.

Authors:  Maja Tomicic; Mirta Starcevic; Vanja Zach; Jasna Bingulac-Popovic; Zeljka Hundric-Haspl
Journal:  Case Rep Med       Date:  2009-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.